GK444

What it means: GK444 selectively targets HDAC1 and HDAC2, two Class I histone deacetylase isoforms that compact chromatin and silence gene transcription by removing acetyl groups from histone lysine residues.

Why it matters:

• HDAC1 and HDAC2 are key drivers of oncogenic transcriptional repression, fibrotic gene programs, and immune checkpoint regulation — making HDAC1/HDAC2 validated targets in cancer biology, fibrosis, and immunology research.
• Isoform selectivity avoids Class IIa/IIb off-targets (e.g., HDAC4, HDAC6), allowing attribution of observed phenotypes specifically to HDAC1/HDAC2 activity.

How to interpret here: HDAC1/HDAC2 selectivity means this compound is appropriate for mechanistic co-IP, ChIP, or gene expression studies where pan-HDAC inhibition would confound interpretation.

What it means: An IC50 of 100 nM for HDAC1 indicates that GK444 achieves 50% inhibition of HDAC1 enzymatic activity at a concentration of 100 nanomolar in a biochemical assay.

Why it matters:

• Nanomolar IC50 potency enables use of GK444 at low concentrations, minimizing the risk of non-specific cytotoxicity or off-target effects in cell-based assays.
• A well-defined IC50 for HDAC1 provides a reference point for dose-response curve design and comparison to published HDAC1-selective inhibitor benchmarks.

How to interpret here: For cell experiments, start 5–10× above the enzyme IC50 (∼500 nM–1 μM) and titrate downward; cellular potency typically differs from biochemical IC50 due to membrane permeability and intracellular protein binding.

What it means: An IC50 of 92 nM for HDAC2 shows that GK444 inhibits HDAC2 enzymatic activity with slightly higher potency than HDAC1 (92 nM vs 100 nM), placing both values in the same nanomolar potency class.

Why it matters:

• HDAC2 is specifically implicated in the repression of anti-inflammatory and anti-fibrotic gene programs; its selective inhibition is mechanistically relevant to pulmonary fibrosis, colitis, and neurological disease research.
• Near-equipotent inhibition of HDAC1 (100 nM) and HDAC2 (92 nM) means GK444 can be used to study HDAC1/2 co-repressor complexes (e.g., NuRD, Sin3) that require both isoforms.

How to interpret here: The 92 nM HDAC2 IC50 supports use of GK444 at 10–100 nM range for acute HDAC2-knockdown mimicry experiments in vitro.

What it means: GK444 is supplied as a dry powder, the preferred form for long-term stability storage of small molecule inhibitors.

Why it matters:

• Powder form avoids solvent-mediated degradation during shipping and storage; you prepare fresh stock solutions at the concentration and solvent of your choice.
• Stability as powder at −20 °C is rated for up to 3 years, significantly longer than solubilized stocks (−80 °C, 1 year).

How to interpret here: Upon receipt, dissolve GK444 powder in DMSO to prepare a 10–50 mM master stock. Aliquot immediately to avoid repeated freeze-thaw degradation. Do not dissolve directly in aqueous buffers — use DMSO first, then dilute into aqueous medium to ≤0.1% final DMSO.

What it means: GK444 powder should be stored at −20 °C (stable for 3 years); once dissolved in solvent, store the solution at −80 °C (stable for 1 year).

Why it matters:

• Correct temperature storage is critical to maintaining the IC50 values of 100 nM (HDAC1) and 92 nM (HDAC2); degraded compound may show reduced potency without visible signs of decomposition.
• Solvent stocks are less stable than powder — storing DMSO stocks at −80 °C rather than −20 °C substantially extends shelf life.

How to interpret here: If receiving for long-term use, keep the bulk powder at −20 °C and prepare fresh DMSO stocks in small aliquots. Return powder vials to −20 °C promptly after weighing.

What it means: GK444 has documented or mechanistically predicted activity across four signaling contexts: chromatin/epigenetic remodeling, DNA damage response, immune signaling, and inflammatory pathways — all driven by its HDAC1/2 inhibitory mechanism.

Why it matters:

• HDAC1/2 are core components of NuRD, Sin3, and CoREST co-repressor complexes — linking them to chromatin compaction and epigenetic silencing relevant to cancer and development research.
• HDAC2 inhibition has been shown to sensitize cells to DNA damage agents and modulate inflammatory gene programs (e.g., COL1A1, TGF-β1 targets), making GK444 relevant to combination therapy and fibrosis studies.

How to interpret here: This multi-pathway activity profile means GK444 may have broad utility but users should confirm target engagement (e.g., histone H3K9/H3K27 acetylation by WB) in their specific model system.

What it means: GK444 is described as a selective HDAC1/2 inhibitor, meaning it demonstrates significantly greater inhibitory activity against HDAC1 (100 nM) and HDAC2 (92 nM) compared to other HDAC family members.

Why it matters:

• Selectivity is essential for attributing phenotypic outcomes (e.g., anti-fibrotic, anti-proliferative) to HDAC1/2 specifically, rather than pan-HDAC inhibition artifacts common with first-generation inhibitors.
• HDAC1/2-selective inhibitors reduce the risk of the cardiotoxicity and thrombocytopenia associated with pan-HDAC inhibitors, making them useful for extended in vivo dosing regimens.

How to interpret here: Run a selectivity counter-screen against HDAC3 and HDAC6 if your study requires rigorous isoform attribution; published selectivity data for GK444 against all 11 HDAC isoforms is available in the primary reference [1].